Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein (ISSP-001)

This study has been completed.
Sponsor:
Information provided by:
Istituto Superiore di Sanità
ClinicalTrials.gov Identifier:
NCT00529698
First received: September 13, 2007
Last updated: February 28, 2011
Last verified: July 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Estimated Primary Completion Date: No date given
No publications provided by Istituto Superiore di Sanità

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):